Cargando…

Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability

Detalles Bibliográficos
Autor principal: Fagiolini, Andrea
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991974/
http://dx.doi.org/10.1186/1744-859X-9-S1-S60
_version_ 1782192683016519680
author Fagiolini, Andrea
author_facet Fagiolini, Andrea
author_sort Fagiolini, Andrea
collection PubMed
description
format Text
id pubmed-2991974
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29919742010-11-26 Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability Fagiolini, Andrea Ann Gen Psychiatry Meeting Abstract BioMed Central 2010-04-22 /pmc/articles/PMC2991974/ http://dx.doi.org/10.1186/1744-859X-9-S1-S60 Text en Copyright ©2009 Fagiolini; licensee BioMed Central Ltd.
spellingShingle Meeting Abstract
Fagiolini, Andrea
Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title_full Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title_fullStr Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title_full_unstemmed Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title_short Aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
title_sort aripiprazole in bipolar disorder: clinical strategies to maximize efficacy and tolerability
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991974/
http://dx.doi.org/10.1186/1744-859X-9-S1-S60
work_keys_str_mv AT fagioliniandrea aripiprazoleinbipolardisorderclinicalstrategiestomaximizeefficacyandtolerability